Flutikrit SF 500 Capsule contains a combination of Salmeterol (50mcg) and Fluticasone Propionate (500mcg), designed to manage and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol is a long-acting beta2-adrenergic receptor agonist that helps relax the muscles in the airways, improving airflow and making breathing easier. Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways, thereby decreasing the frequency and severity of asthma attacks and COPD exacerbations. This dual-action formulation provides both immediate bronchodilation and long-term control of airway inflammation. Flutikrit SF 500 is typically prescribed for patients who require regular maintenance therapy to prevent bronchospasm and improve lung function. It is important to use this medication consistently as directed by a healthcare professional, as it is not intended for relief of acute bronchospasm or sudden breathing difficulties. Common side effects may include throat irritation, hoarseness, and oral thrush, which can be minimized by rinsing the mouth after use. Patients should consult their doctor before starting Flutikrit SF 500, especially if they have a history of heart problems, infections, or are pregnant or breastfeeding.